The Global Institute for Novel Nicotine (GINN) has officially launched. With a dedicated focus on shaping the future of novel nicotine, GINN will be a key player in advocating for responsible practices and evidence-based policies.

Shem Baldeosingh, Director of GINN, celebrated the launch, stating, "Today marks a pivotal moment for novel nicotine as we embark on a journey to change the future prospects for nicotine pouches, heat not burn and other emerging nicotine products. We will be the leading voice for novel nicotine, advocating for: their potential as harm reduction alternatives, responsible industry practices, and evidence-based policies. We believe in fostering innovation across the entire nicotine supply chain, as well as collaborating with policymakers and other international stakeholders”.

As GINN takes centre stage in the evolving landscape of reduced-risk nicotine products, it looks forward to collaborating with industry partners, regulatory bodies, and stakeholders. GINN is steadfast in its mission to lead the industry conversation and promote science-led practices for the benefit of public health, and invites new members to join at here [link to contact page].

Admittance to membership is not permitted to any entity owned by multinational or transnational tobacco companies.